STRUCTURE OF DIRECT COST OF CARE OF PATIENTS TREATED FOR SEVERE RHEUMATOID ARTHRITIS IN FRANCE

被引：0
|
作者：
Fagnani, F. [1 ]
Laurendeau, C. [1 ]
Fautrel, B. [2 ]
Joubert, J. M. [3 ]
Cukierman, G. [3 ]
Gourmelen, J. [4 ]
机构：
[1] Cemka Eval, Bourg La Reine, France
[2] Univ Paris 06, Paris, France
[3] UCB Pharma, Colombes, France
[4] Inserm U1018, Villejuif, France
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A443 / A443
页数：1
相关论文
共 50 条
  • [21] IDENTIFYING TRAJECTORIES OF REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED IN A TERTIARY CARE CENTRE
    Redeker, I.
    Gildemeister, N.
    Andreica, I.
    Kiefer, D.
    Baraliakos, X.
    Braun, J.
    Kiltz, U.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1221 - 1222
  • [22] Identifying Trajectories of Remission in Patients with Rheumatoid Arthritis Treated in a Tertiary Care Centre
    Redeker, Imke
    Gildemeister, Nils
    Andreica, Ioana
    Kiefer, David
    Baraliakos, Xenofon
    Braun, Juergen
    Kiltz, Uta
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1793 - 1795
  • [23] THE COST OF CARE OF RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS PATIENTS IN TERTIARY CARE RHEUMATOLOGY UNITS IN TURKEY
    Malhan, S.
    Pay, S.
    Ataman, S.
    Dalkilic, E.
    Dinc, A.
    Erken, E.
    Ertenli, I
    Ertugrul, E.
    Gogus, F.
    Hamuryudan, V
    Inanc, M.
    Karaaslan, Y.
    Karadag, O.
    Karakoc, Y.
    Keskin, G.
    Kisacik, B.
    Kiraz, S.
    Oksel, F.
    Oksuz, E.
    Parildar, T.
    Sari, I
    Soy, M.
    Senturk, T.
    Taylan, A.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A306 - A306
  • [24] The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey
    Malhan, S.
    Pay, S.
    Ataman, S.
    Dalkilic, E.
    Dinc, A.
    Erken, E.
    Ertenli, I.
    Ertugrul, E.
    Gogus, F.
    Hamuryudan, V.
    Inanc, M.
    Karaaslan, Y.
    Karadag, O.
    Karakoc, Y.
    Keskin, G.
    Kisacik, B.
    Kiraz, S.
    Oksel, F.
    Oksuz, E.
    Pirildar, T.
    Sari, I.
    Soy, M.
    Senturk, T.
    Taylan, A.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (02) : 202 - 207
  • [25] Severe infection risk in patients treated with biologics for rheumatoid arthritis: a systematic review protocol
    Makimoto, Kiyoko
    Konno, Rie
    Kanzaki, Hatsumi
    Kinoshita, Atsushi
    [J]. JBI EVIDENCE SYNTHESIS, 2021, 19 (08) : 1992 - 1998
  • [26] RISK OF MALIGNANCY AND SEVERE INFECTION IN A POPULATION OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BIOLOGICS OR DMARDS
    Gilliaux, Q.
    Stoenoiu, M.
    de Bellefon, L. Meric
    Depresseux, G.
    Toukap, A. Nzeusseu
    Lauwerys, B.
    Houssiau, F.
    Durez, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 711 - 712
  • [27] Age as a risk factor for severe myelotoxicity in rheumatoid arthritis patients treated with oral methotrexate
    Rodriguez, M
    Ulibarrena, C
    Fernandez, L
    Lopez, G
    FernandezSueiro, L
    Willisch, A
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 392 - 392
  • [28] Direct cost of care for patients with schizophrenia treated with haloperidol in an emergency unit
    Ricard, N
    Sauriol, L
    Bélanger, MC
    Chouinard, G
    [J]. PSYCHIATRIC SERVICES, 1999, 50 (10) : 1287 - 1288
  • [29] Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France
    Mariette, X
    Cazals-Hatem, D
    Warszawki, J
    Liote, F
    Balandraud, N
    Sibilia, J
    [J]. BLOOD, 2002, 99 (11) : 3909 - 3915
  • [30] ESTIMATION OF THE IMPACT OF A STRATEGY TO OPTIMIZE COSTS ON NATIONAL HEALTH-CARE SYSTEM IN PATIENTS WITH RHEUMATOID ARTHRITIS: A DIRECT COST ANALYSIS
    Aranda, D. F.
    Benincasa, T.
    Romero-Sanchez, C.
    Chila, L.
    Bautista-Molano, W.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 509 - 510
12345